Collagen Type I C Telopeptide (CTX) Biomarker Testing
It measures bone breakdown activity to assess fracture risk and treatment response, with easy ordering and Quest lab access through Vitals Vault.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
Your bones are constantly being remodeled. Old bone is broken down and new bone is built, and the balance between those two processes affects bone strength over time.
A Collagen Type I C Telopeptide (CTX) test measures a byproduct released when bone is broken down. Because CTX changes faster than a bone density scan, it can help you and your clinician see whether bone loss is active right now and whether a treatment plan is working.
CTX is most useful when you interpret it in context, including your age, menopause status, medications, and how the sample was collected. It is a tool for clinician-directed care, not a standalone diagnosis.
Do I need a Collagen Type I C Telopeptide (CTX) test?
You may consider a CTX test if you are evaluating bone health beyond a one-time bone density (DEXA) result. CTX can be helpful when you want a more “real-time” read on bone breakdown, especially if you have risk factors for osteoporosis or fractures.
This test is commonly ordered when you are starting, stopping, or monitoring osteoporosis therapy. For example, CTX can help show whether anti-resorptive medications (such as bisphosphonates or denosumab) are suppressing bone resorption as expected, or whether bone turnover is rebounding after a change in therapy.
CTX can also be useful if you have unexplained low-trauma fractures, rapid bone loss on DEXA, or medical conditions and medications that affect bone (such as hyperthyroidism, long-term glucocorticoids, or certain cancer treatments). If you are premenopausal, pregnant, or have kidney disease, interpretation needs extra care because CTX can shift for reasons unrelated to osteoporosis.
If you already have a CTX result, the next step is usually to review it alongside other bone markers, vitamin D status, kidney function, calcium and parathyroid hormone (PTH), and your clinical history with your clinician.
CTX is measured on validated laboratory assays performed in CLIA-certified labs; results support medical decision-making but do not diagnose osteoporosis by themselves.
Lab testing
Order a CTX test and schedule your draw when it fits your week.
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
If you want to check bone resorption without waiting for a referral, you can order CTX through Vitals Vault and complete your blood draw at a participating Quest location.
After your results are ready, you can use PocketMD to get plain-language context for what “low,” “in range,” or “high” can mean for you, plus questions to bring to your clinician. This is especially helpful for CTX because timing, fasting status, and medications can change the number.
Vitals Vault also makes it easy to trend CTX over time. For monitoring, your clinician will often care more about the direction and percent change than a single value, as long as testing conditions are consistent.
If your CTX suggests higher bone turnover, you can add companion labs to map out common drivers (like vitamin D, calcium/PTH balance, thyroid status, and kidney function) and make your follow-up more targeted.
- Order online and draw at a Quest location
- PocketMD guidance for next steps and retest timing
- Designed for trending results over time
Key benefits of CTX testing
- Gives a near-term snapshot of bone resorption (breakdown), which can change faster than bone density.
- Helps monitor response to anti-resorptive osteoporosis therapies by showing whether bone turnover is being suppressed.
- Supports treatment planning when DEXA results and fracture risk do not fully match your symptoms or history.
- Can help identify unusually high bone turnover that may warrant evaluation for secondary causes of bone loss.
- Useful for tracking rebound increases in bone resorption after stopping or delaying certain osteoporosis medications.
- Adds context when paired with bone formation markers and mineral labs (vitamin D, calcium, PTH) to interpret the “why.”
- Makes it easier to retest under consistent conditions and trend changes with PocketMD support.
What is Collagen Type I C Telopeptide (CTX)?
Collagen Type I makes up most of the organic framework of your bones. When specialized cells called osteoclasts break down bone, fragments of collagen are released into the bloodstream. CTX (often reported as serum beta-CTX or C-terminal telopeptide of type I collagen) is one of those fragments.
Because CTX reflects the rate of bone resorption, it is considered a bone turnover marker. High turnover can contribute to bone loss over time, while very low turnover can occur with potent anti-resorptive therapy or in certain low-turnover states.
CTX is not the same as a bone density test. DEXA estimates how much mineral is in your bones, while CTX reflects how actively bone is being broken down at the time of testing. Many clinicians use CTX to monitor therapy or to understand whether bone loss is currently active.
Why timing matters for CTX
CTX has a strong daily rhythm. It tends to be highest in the early morning and lower later in the day, and it can drop after eating. For monitoring, your clinician may recommend drawing the test in the morning and fasting, and repeating future tests under the same conditions so changes are easier to interpret.
How CTX is used in osteoporosis care
CTX is often used to assess baseline bone resorption, to confirm that therapy is having the expected effect, and to guide follow-up timing. In many cases, the goal is not a specific “perfect” number but a meaningful reduction from your baseline or a stable low level while on treatment.
What do my CTX results mean?
Low CTX
A low CTX result usually means bone resorption is suppressed. This can be expected if you are taking an anti-resorptive medication and the therapy is working as intended. It can also occur if the sample was drawn later in the day or after eating, which can lower CTX compared with a fasting morning draw. If CTX is very low and you are not on therapy, your clinician may interpret it alongside other markers to make sure the result fits your overall bone and metabolic picture.
CTX in range (or at your treatment target)
An in-range CTX result suggests bone resorption is within the expected range for the lab’s reference interval, but “normal” depends on context. Premenopausal vs postmenopausal status, recent fractures, and medication use can shift what is expected. For monitoring, many clinicians focus on whether your CTX is stable over time or has decreased appropriately from your baseline after starting therapy. If your DEXA and fracture risk are low, an in-range CTX can be reassuring when it matches the rest of your evaluation.
High CTX
A high CTX result suggests increased bone resorption, meaning bone is being broken down more quickly. In postmenopausal osteoporosis, higher CTX can reflect estrogen-related increases in turnover and may correlate with faster bone loss. It can also rise with hyperthyroidism, vitamin D deficiency with secondary hyperparathyroidism, recent fracture healing, prolonged immobilization, or certain medications. A single high value is not a diagnosis, but it is often a reason to review secondary causes and consider repeat testing under standardized conditions.
Factors that influence CTX
CTX varies with time of day and food intake, so morning fasting samples are often preferred for comparability. Menopause status, age, and recent fractures can raise CTX, while effective anti-resorptive therapy can lower it. Kidney function can affect clearance of some bone markers, and lab methods and reference ranges vary, so it helps to trend results using the same lab when possible. Supplements and medications that affect calcium and bone metabolism (including thyroid hormone dose changes, glucocorticoids, and osteoporosis drugs) can also shift CTX over weeks to months.
What’s included
- C Telopeptide (Ctx)
Frequently Asked Questions
Do I need to fast for a CTX test?
Often, yes—fasting morning collection is commonly recommended because CTX drops after meals and varies through the day. If you are trending CTX over time, try to repeat the test under the same conditions (time, fasting status, and lab) so changes are meaningful.
What is a normal CTX level?
“Normal” depends on the lab, the assay, your age, and whether you are premenopausal or postmenopausal. Your report will include a reference interval, but your clinician may focus more on your baseline and the direction of change, especially when monitoring treatment.
How often should CTX be retested?
For treatment monitoring, clinicians may recheck CTX a few months after starting or changing therapy, then periodically to confirm stability. The best interval depends on the medication, your fracture risk, and how consistent your prior results have been.
Can CTX be high after a fracture?
Yes. Bone remodeling increases during fracture healing, and CTX can rise temporarily. If you recently had a fracture or surgery, tell your clinician so they can interpret the result in that context or choose a better time to retest.
What tests are commonly ordered with CTX for bone health?
CTX is often interpreted alongside vitamin D (25-OH), calcium, phosphorus, parathyroid hormone (PTH), kidney function (creatinine/eGFR), and sometimes thyroid tests. A bone formation marker (such as P1NP) may also be used to understand overall turnover balance.
Is CTX the same as a bone density scan (DEXA)?
No. DEXA measures bone mineral density, which changes slowly over time. CTX is a blood marker of bone breakdown that can change more quickly and is often used to monitor therapy or understand current turnover.
Can osteoporosis medication lower CTX too much?
Potent anti-resorptive therapy can drive CTX low, which is often the intended effect. Whether a value is “too low” depends on your medication, duration of therapy, symptoms, and overall risk profile, so it is best discussed with your clinician rather than judged from a single number.